Juvederm Volux with Lido (2x1 ml)

Dosage is individualized based on the patient's anatomical needs. For jawline definition, 2 ml to 4 ml (1-2 syringes) per session is common. For chin projection, 1 ml is typically sufficient for a significant change. Clinicians should evaluate if subtle structural support is achieved before adding additional product for high-projection goals.

Expect transient side effects such as localized swelling, tenderness, and potential purple bruising at the deep injection sites. Because Volux is a high-G-prime gel, patients may feel "firmness" or pressure in the jaw for 1-2 weeks. To ensure a quick recovery, follow our expert aftercare guide. Any persistent blanching requires immediate evaluation for vascular occlusion.

Patients should avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase post-filler swelling and worsen bruising at the deep injection points required for jawline contouring.

Volux uses a highly cross-linked HA matrix that acts as a structural scaffold, mimicking the projection of bone. Unlike skin boosters, which prioritize hydration, Volux provides the mechanical "lift" needed to reshape the mandibular angle and chin without shifting or migrating over time.

This treatment is strictly contraindicated. There is no clinical safety data regarding the use of high-density Vycross fillers during gestation. We recommend postponing elective structural treatments until after childbirth.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has completely concluded to ensure maximum safety for both mother and infant during elective aesthetic procedures.

The formulation contains 25 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride for a comfortable treatment experience.